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Abstract. Thrombin,  in addition to its central  role in 
hemostasis, possesses diverse cellular bioregulatory 
functions implicated in wound healing,  inflammation, 
and atherosclerosis.  In the present study we demon- 
strate that thrombin molecules modified either at the 
procoagulant or catalytic sites induce endothelial cell 
(EC) adhesion,  spreading,  and cytoskeletal reorganiza- 
tion.  The most potent adhesive thrombin analogue 
(NO2-o~-thrombin)  was obtained by nitration of tyro- 
sine residues.  The cell adhesion promoting activity of 
NO2-o~-thrombin  was blocked upon the formation of 
thrombin-antithrombin  III (ATIII)  complexes and by 
antiprothrombin  antibodies, but was unaffected by 
hirudin.  Arg-Gly-Asp-containing peptides,  fully in- 
hibited EC adhesion to NO2-o~-thrombin,  while syn- 
thetic peptides corresponding to thrombin "Loop B" 
mitogenic site and the thrombin-derived chemotactic 
fragment "CB67-129",  were uneffective. Im- 
munofluorescence studies indicated that EC adhesion 
to NO2-ct-thrombin  was followed by cell spreading,  ac- 
tin microfilament assembly, and formation of focal 
contacts.  By the use of specific antibodies, the 
vitronectin (vn) receptor (¢v#3) was found to be local- 
ized in clusters upon cell adhesion to NO2-o~- 
thrombin.  An anti otv/~3 antibody blocked EC adhesion 
and spreading while antifibronectin (fn) receptor 
(ol5~)  antibodies were uneffective. While native throm- 
bin exhibited a very low cell attachment activity, 
thrombin that was incubated at 37°C before coating of 
plastic surfaces induced EC attachment and spreading. 
We propose that under certain conditions the naturally 
hindered RGD domain within thrombin is exposed for 
interaction with c~433 on EC. This in turn promotes 
cell adhesion,  spreading,  and reorganization of 
cytoskeletal elements,  which may altogether contribute 
to repair mechanisms in the disturbed vessel wall. 
This study defines a new biological role of thrombin 
and characterizes a  new recognition mechanism on EC 
for this molecule. 
T 
rIE integrity  of the vascular system is maintained  by 
factors that mediate the attachment  and growth of en- 
dothelial  cells (ECs). ~ The luminal  surface of blood 
vessels is composed of closely apposed ECs providing a non- 
thrombogenic  surface designed to maintain  blood fluidity 
(31). Upon vascular injury,  exposure of blood to thrombo- 
genie subendothelial  structures stimulate  rapid generation 
of a  hemostatic plug consisting  of platelets  and fibrin  (2, 
33, 41). 
Thrombin (E.C. 3.4.21.5),  the final activation  product of 
the clotting cascade, is responsible for converting fibrinogen 
to fibrin monomers that polymerize spontaneously to form 
a typical clot mesh. In addition to its major role in hemosta- 
1. Abbreviations  used in this paper: ABAE, adult bovine aortic endothelial 
cells; ATIII, antithrombin III; BAEC, bovine aortic endothelial cells;  EC, 
endothelial cells; ECM, extracellular matrix; HUVEC, human umbilical 
vein endothelial cells; MeSO2, methysulfonyl fluoride;  TLCK, N-u-tosyl- 
L-lysylchloromethyl-ketone. 
sis,  thrombin,  a multifunctional  serine protease, degrades 
various constituents  of the extracellular  matrix (ECM) (28) 
and  induces  cellular  responses  such  as  proliferation  and 
chemotaxis (3, 4, 6, 9, 36). We have recently demonstrated 
that  thrombin binds to the subendothelial  ECM through  a 
short anchorage binding site, leaving the majority of the mol- 
ecule functional  and available for cellular interactions  (5). 
ECM-immobilized thrombin was found to be protected from 
inactivation  by the  circulating  inhibitor  antithxombin  II1 
(ATIII). Thus, thrombin when sequestered by the ECM may 
exhibit  a localized,  long-acting  stimulation  of surrounding 
tissues (6). Amino acid analysis of thrombin B-chain reveals 
the presence of an Arg-Gly-Asp-Ala  sequence at residues 
187-190 (26). Because thrombin is ubiquitous to injury sites, 
we wondered whether it can participate in EC adhesion and 
thus contribute to repair mechanisms  of vascular lesions.  In 
the present study we demonstrate that thrombin preparations 
modified at either the procoagulant or catalytic sites induces 
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ament bundles.  This  EC adhesion was inhibited by RGD 
containing peptides, was accompanied by clustering of  vitro- 
nectin receptors in focal contacts, and was inhibited by anti- 
bodies directed against the vitronectin receptor. We propose 
that upon certain modifications of thrombin,  the naturally 
hindered RGD domain is exposed for interactions with the 
vitronectin receptor  (c~v/$3) on the EC surface. 
Materials and Methods 
Ce//s 
Cloned populations of adult bovine aortic ECs (ABAE) were isolated as de- 
scribed (30).  Ceils were cultured in DME (1  g  glucose/liter) containing 
10% bovine calf serum, penicillin (50 U/rni), and streptomycin (50 #g/ml) 
(Gibco Laboratories, Grand Island, NY) at 37°C in 10% CO2 humidified 
incubators. Partially purified, brain-derived bFGF (100 ng/ml) was added 
every other day during the phase of active cell growth. Human umbilical 
vein ECs (HUVEC) were obtained and cultured as described (15). The cells 
were grown to confluence in plastic flasks (Falcon Labware, Becton Dickin- 
son & Co., Oxnard, CA) in medium 199 (M199)  supplemented with 20% 
FCS and antibiotics. Cells were cultured at 37°C in 5% CO2 humidified 
incubators and the medium replaced three times a week. Experiments with 
HUVEC were carded out between the first and fifth passage and with ABAE 
at passage 5-30.  Cells were dissociated with 0.05%  trypsin/0.02% EDTA 
in PBS and subcultured at a split ratio of 1:5. ECs were characterized by 
indirect immunofluorescence using rabbit anti human factor VIII antigen 
(Behringwerke Ag, Mailburg, Federal Republic of Germany). 
Human Thrombin Preparations 
Highly purified human a-thrombin was prepared from fraction IV paste, 
evaluated for purity,  and characterized as described previously (22,  23). 
Nitration of tyrosine residues to  yield NO2-a-thrombin was performed 
using tetranitromethane at pH 7.8 as described (36). Specific activity was 
reduced from 3,975  to 14 clotting U/rag protein and the p-nitropbenyl-p- 
guanidinobenzoate-titratable active sites were reduced from 84.4 to 66%. 
The derivatives ct-thrombin, methylsulfonyl fluoride (MeSO2)-c~-throm- 
bin, TLCK-t~-thrombin and exosite afffinity-labeled thrombin were prepared 
as described previously (6). Modified thrombin preparations were dialyzed 
extensively against 0.75 M  NaC1, and stored frozen at  -70°C. Thrombin 
chemotactic fragment ("CB67-129")  and the synthetic peptides correspond- 
ing to residues 36%380,  371-380,  and 375-380  of thrombin B-chain, as 
well as various  constructs of this region, were kindly provided by Dr.' 
George D. Wilner (American Red Cross, Albany, NY). 
Preparation of Coated Surfaces 
Thrombin and  various  modified thrombin preparations Were diluted to 
10-50/~l/ml in PBS containing 0.1% BSA and adsorbed onto the surface 
of 16-ram wells of 4-well plates (Nunc, Roskilde, Denmark) by incubation 
at 4°C overnight. Unbound thrombin was removed and the dishes washed 
three times with PBS. To determine the amount of thrombin adsorbed to 
the surface of the dish, thrombin was iodinated as described (27)  and the 
amount of protein adsorbed to the tissue culture plastic determined by 3,-count- 
ing of radioactive material solubilized with 1 N NaOH. In few experiments 
human plasma vitronectin, purified as described (42), and human plasma 
fibronectin, purified by affinity chromatography on gelatin-Sepharose (20) 
were used to coat culture dishes and glass coverslips, as described. Glass 
coverslips (10 mm diameter) were cleaned by sonication for 10 rain, im- 
mersed  in ethanol/ether (l:l[vol/vol]) for 2 h and dried before  placing in 4-well 
tissue culture plates (Falcon Labware, Oxnard CA). The coverslips were 
coated with 0.3 ml of either vitronectin (7 #g/ml), ot-thrombin,  or NO2- 
~-thrombin (100  #g/ml) in PBS containing Ca  2+ and Mg  2+, pH 7.4,  for 
2 h at 370C. Residual protein binding sites on coverslips were saturated by 
further incubation (30 min, 370C)  with  1%  BSA (fatty  acid free; Sigma 
Chemical Co., St. Louis, MO) in Ca2+,Mg 2+ containing PBS. Coverslips 
were then washed twice with PBS before cell seeding. 
Preparation of  ECM 
Corneal endothelial cells were plated at an initial density of 4  ×  10  a ceils 
per 35-mm dish (Falcon Labware) and maintained as described for aortic 
EC except that 5% dextran T-40 (Pharmacia,  Uppsala, Sweden) was in- 
cluded in the growth medium to obtain a thicker ECM layer. 6-8 d after 
the cells reached confluency the subendothelial ECM was exposed by dis- 
solving (3 min, 22°C) the cell layer with a solution containing 0.5% Triton 
X-100 and 20 mM NI-hOH in PBS (25). The ECM remained intact, firmly 
attached to the entire area of the tissue culture dish and free of nuclear 
debris. 
Antibodies 
Antibodies recognizing the vitronectin receptor (~v~s) and the fibronectin 
receptor (~5/31) were used.  ctv~3 antibodies were the following.  (a)  A 
purified human platelet GplIIa  rabbit antiserum that ~cognizes integrin 
/~3 (24, 37) was prepared in our laboratory as previously described (15). (b) 
mAb LM142 directed against uv chain. (c) mAb LM609 directed to t~vB3 
complex. These mAbs were kindly donated by Dr. D. Cheresh (Department 
of Immunology, Scripps Clinic and Research Foundation, La Jolla, CA) 
(11). The anti-t~5/~l antibodies were: (a) a goat antiserum directed to purified 
a5/31 prepared in our laboratory and characterized elsewhere (12);  (b) a 
rabbit antiserum to the ct5 cytoplasmic domain, kindly donated by Dr. 
J.  A. McDonald (Washington University, School of Medicine, St. Louis, 
MO);  and mAb (B1E5) directed to c~5 chain was obtained from Dr.  C. 
Damsky (Department of Anatomy, University of California San Francisco, 
CA). Preimmune goat and rabbit sera and a mAb (10E3) to human platelet 
GplIb-IIIa, which does not recognize endothelial cells (10) (kindly donated 
by Dr. B. S. Coller, State University of  New York at Stony Brook, NY) were 
used as negative controls. The localization of vinculin was assayed with a 
mouse mAb to chicken gizzard vinculin cross reacting with the mammalian 
vinculin (clone V1N-11-5; code 6501; Bio Makor, Rehovot, Israel). Anti- 
prothrombin antibodies were purchased from DAKOPATTS (Copenhagen, 
Denmark). 
Attachment Assay 
Confluent endothelial cells were dissociated with trypsin-EDTA solution 
washed once in growth medium, and resuspended in DME containing 0.2 % 
BSA. Cells (1.3  ×  105 cells/well) were added to each protein-coated well 
and incubated at 37°C for 2 h. The plates were washed three times with PBS 
and the firmly attached cells were fixed with 3 % paraformaldehyde. Fixed 
cells were rinsed with 0.1 M borate buffer (pH 8.5), stained (10 rain at 220C) 
with 0.1 ml methylene  blue (1% in 0.1 M borate buffer, pH 8.5) per well, and 
washed four times in borate buffer. This procedure removed practically all 
noncell-bound dye. Specific cell incorporated methylene blue was dissolved 
with 0.1 N HCI (0.2 nil/well, 40 min, 37°C) and determined by its absor- 
bance at 600 nm. Uptake of methylene blue is linearly correlated to the 
number of viable cells  (29). 
To determine whether protein synthesis and/or secretion participate in 
thrombin induced cell attachment, ECs were plated with or without 5 ng/ml 
emetine (Sigma Chemical Co.) or 0.7 ng/ml monensin (Sigma Chemical 
Co.) to inhibit protein synthesis and secretion, respectively (14,  17, 41). 
Cells were treated with the drugs 1 h before plating on specific substrates 
and kept in the presence of the drugs during the adhesion assay. Each point 
is the average of triplicate wells and standard error did not exceed +5% 
of the mean. Each experiment was performed at least three times yielding 
comparable results and the variation between different determinants did not 
exceed 15 %. 
RGD-containing Peptides 
The synthetic tetra-, penta-, and hexapeptides (GRGD, GRGDS, GRGDSP, 
GRGESP) were obtained from Peninsula Laboratories, Inc. (Belmont, CA). 
In some experiments ECs were plated in the presence of  these synthetic pep- 
tides and analyzed for the extent of cell attachment. 
Fluorescence Studies 
For immunofluorescence experiments, detached cells were washed once in 
growth medium resuspended in serum-free M199 medium at a concentra- 
tion of 1.5-2  ×  105 cells/ml, and 0.3 ml of the cell suspension was seeded 
on each coated coverslip. After the indicated time of incubation at 37°C, 
the wells were washed three times with  1 ml PBS containing Ca  +2 and 
Mg  +2. The coverslip-attached cells were fixed in 3% formaldehyde (from 
paraformaldehyde) in PBS, pH 7.6, containing 2 % sucrose, for 5 min at 
room temperature. After rinsing in PBS, cells were permeabilized by soak- 
ing the coverslips for 3-5 rain at 0°C in Hepes-Triton X-100 buffer (20 mM 
Hepes, pH 7.4,  300 mM sucrose, 50 mM NaC1, 3 mM MgCI2,  and 0.5% 
Triton X-100).  This procedure of fixation and permeabilization has been 
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Figure 1. EC adhesion to various modified thrombin preparations. 
(A) Time course. Dishes were coated with different thrombin ana- 
logues (10-50/~g/ml) in PBS containing 0.1% BSA. EC (1.3 x  l0  s 
cells/well) were added and unattached cells removed at various time 
intervals after seeding. Substrates:  (e) NO2-ot-thrombin, (*) Exo 
site affinity label-thrombin,  (-) MeSO2-thrombin,  (*) ~-throm- 
bin,  (n) TLCK-ot-thrombin,  (x) DIP-u-thrombin,  (<>) u-throm- 
bin,  (o) BSA. (B) Dose dependence.  4-well plates  were coated 
with  increasing  concentrations  of NO2-c~-thrombin. ECs (1.3  x 
105  cells/well)  were  seeded  and  unattached  ceils  removed after 
2 h incubation at 37°C. The degree of cell attachment,  expressed 
as  percentage  of attached  cells  relative  to the  number of cells 
seeded, was evaluated by the uptake of methylene blue, as described 
in Materials  and Methods. 
successfully used in various studies with EC (15-17).  To show F-actin in 
the process of cell spreading and microfilament organization, fixed and per- 
meabilized cells were stained with 2/~g/ml rhodamine-labeled phailoidin 
(R-PHD, a kind gift of Dr. T. Wieland, Max Planck Institute for Experimen- 
tal  Medicine,  Heidelberg,  FRG)  for  30  min  at  37°C.  Indirect  im- 
munofluorescence staining was performed as reported (15-17).  Briefly,  the 
primary antibody was layered on fixed an permeabilized cells and incubated 
in a humid chamber for 30 rain. After riming in PBS-0.2% BSA, coverslips 
were incubated with the appropriate rhodamine-tagged secondary antibody 
(DAKOPATTS) for 30 pain at 37°C in the presence  of  2/zg/ml of fluorescein- 
labeled phalloidin. Coverslips were then mounted in 50%  glycerol-PBS. 
Observations  were  carried  out  in  a  Zeiss  Axiophot  photomicroscope 
equipped  for  epifluorescence  and  interference  refection  microscopy. 
Fluorescence images were recorded on Kodak T-Max 400 films exposed at 
1000 ISO and developed in Kodak T-Max developer for 10 min at 200C. 
Results 
Endothelial Cell Adhesion to Thrombin 
Fig.  1 A demonstrates the attachment of bovine aortic en- 
dothelial cells (BAEC)  to t~-thrombin and to a  variety of 
thrombin  species  that  were  chemically modified to  alter 
thrombin  procoagulant  or  esterolytic  functions.  NO2-t~- 
thrombin was found to be the most potent adhesive substra- 
tum, inducing attachment of ,',,80% of the cells within 2 h. 
Modified thrombin preparations inactivated by the fibrinopep- 
tide exosite affinity label (Exo-a-thrombin) and the mesyl- 
conjugated active site serine (MeSO2-ot-thrombin)  were highly 
active in promoting BAEC attachment.  T-Thrombin, lacking 
the procoagulant site of thrombin, was also active. In contrast, 
the native enzyme (t~-thrombin) and the esterolytically inac- 
tive forms, N-t~-tosyl-L-lysylchoromethyl-ketone (TLCK)- 
u-thrombin  and  diisopropylfluorophosphate-ot-thrombin, 
were poorly active and the level of cell attachment was only 
slightly above that observed on noncoated surfaces. 
To  further  investigate  the  requirements  for  thrombin- 
mediated induction  of EC adhesion,  the following experi- 
ments were performed using NO2-t~-thrombin as the adhe- 
sive substratum. Fig.  1 B demonstrates that cell attachment 
was  dependent  on  the  concentration  of NO2-c~-thrombin 
used to coat the dishes, reaching saturation at 20-50/~g/ml. 
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Figure 2. Effect of synthetic hexapeptides on EC attachment.  (A) 
NO2-a-thrombin.  ECs  were  tested for  attachment  to  NO2-u- 
thrombin (20/~g/well) in the presence of increasing concentrations 
of either GRGDSP (o), or the control peptide GRGESP (o). The 
attachment of EC (2 h, 37°C) was analyzed by the methylene blue 
uptake assay. Cell adherence was expressed as percentage of cells 
seeded (1.3 x  1@ cells/well). (B) Various modified thrombin ana- 
logues in the absence (D) and presence (o) of GRGDSP peptide. 
T-Th, T-thrombin; Exo-o~-Th, Exo-site affinity label thrombin; Me- 
o~-Th, MeSO2-0t-thrombin; NO2-o~-Th, NO2-a-thrombin. 
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Figure 3. Schematic  presentation of the human thrombin B-chain. 
Residues  are aligned  with residues  16-245 of bovine chymotryp- 
sinogen. Individual residues are identified by the single letter code, 
Tyr (Y) in hexagons.  The carbohydrate (CHO) attachment at Asn 
60E is assumed from the bovine enzyme (26). The disulfide bonds 
(S-S) are shown above the sequence line. 
Effect of  Synthetic Peptides on EC Attachment to 
NOz-~-thrombin 
We next investigated the involvement of RGD in EC attach- 
ment to thrombin.  For this  purpose  increasing concentra- 
tions (0.001-0.1 mM) of the synthetic hexapeptides GRGDSP 
or GRGESP were tested for their ability to inhibit EC attach- 
ment to NO2-o~-thrombin.  While >95 %  inhibition was ob- 
tained in the presence of 0.01 mlVl GRGDSP, no significant 
inhibition was observed with GRGESP (Fig. 2 A). Similarly, 
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Figure 5. Effect of thrombin inhibitors  on EC attachment to NO2- 
~x-thrombin. Dishes were coated with NO2-~x-thrombin (20/~g/ml, 
0.57 nmol).  Before coating,  NO2-~-thrombin  was incubated  with 
increasing amounts of  hirudin or ATIII  (0.57-2.85  nmol) plus hepa- 
rin (0.3 U/ml), at a ratio of NO2-tx-thrombin:inhibitors  of 1:1 (a, 
A),  1:2 (b, B), or 1:5 (c,  C) for NO2-:Hir and NO2-:ATIII, re- 
spectively. Dishes were also coated with NO2-~x-thrombin (NO2-; 
20/~g/ml, 0.57 nmol),  hirudin (d; 20 ~g/ml, 2.85),  ATIII (D; 171 
/~g/ml,  2.85  nmol),  fibronectin  (E;  30  t*g/ml, 0.57  nmol),  or 
fibronectin/ATIII (F; 30:171 #g/ml; 0.57:2.85 nmol). Attachment of 
EC was analyzed by the methylene blue uptake assay. Adhesion to 
NO2-ct-thrombin was regarded  as  100%. 
ous thrombin preparations (Fig. 2 B). These results indicate 
that the  attachment  activity of various  modified thrombin 
preparations  can be attributed to an RGD sequence in the 
protein.  As  demonstrated  in  Fig.  3,  RGDA  sequence  in 
thrombin is located downstream at residues  187-190 of hu- 
man  thrombin  B-chain,  when  residues  are  aligned  with 
residues  16-245  of bovine  chymotrypsin (26).  Other  de- 
scribed functional domains in thrombin, outside the proteo- 
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Figure 4. Effect of various thrombin fragments on EC attachment 
to NO2-u-thrombin.  Attachment (2  h,  37°C) of EC to NO2-tx- 
thrombin coated dishes in the absence (NO2-) and presence of syn- 
thetic peptides  (20/zg/ml) corresponding to the loop B mitogenic 
site (I, 14 amino acids; H, 10 amino acids; and III, 6 amino acids), 
Loop B (B), the chemotactic peptide CB67-120 (CB), and increas- 
ing concentrations of soluble tx-thrombin (a, 20/zg/ml; b, 10/zg/ml; 
c, 2/zg/ml; d, 0.2/zg/ml). The number of firmly attached ECs was 
determined by the methylene blue uptake assay. Attachment in the 
presence of each protein is expressed  as percentage of the number 
of cells attached to NO2-tx-thrombin alone (=  100%). 
NRS 
1:20 
0  None NO=-  1:100  1:75 1:50 1:25  1:20 
Ab,  Dilution 
Figure 6. Effect of antiprothrombin  antibodies  on EC attachment 
to NO2-oe-thrombin. Increasing amounts of antiprothrombin  anti- 
bodies or normal rabbit  serum (NRS) were incubated  (2 h, 37°C) 
with ECs (1.3  x  105 cells/well)  in contact with NO2-ot-thrombin 
coated wells. Cells were also incubated  in wells coated with NOT 
cx-thrombin alone (NO2-). Attachment of ECs was determined by 
the methylene  blue uptake assay. 100%  =  adhesion to  NO2-tx- 
thrombin alone. 
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tinct  and  separate  regions.  The  Loop-B domain located 
between residues 60 and 61  within the variable region 2 
(VR2) of thrombin B-chain, while the chemotactic pepride 
CB67-129 is located at residues 33-84 according to this num- 
bering system. When the synthetic peptide corresponding to 
Loop B mitogenic site, as well as various constructs of this 
region were tested for their ability to compete with EC at- 
tachment to NO2-o~-thrombin, only 10-20%  inhibition was 
observed. Similarly, the thrombin-derived chemotacric frag- 
ment CB67-129  inhibited EC  attachment to  thrombin by 
,~,15 %. In contrast, soluble cx-thrombin inhibited the attach- 
ment of EC to NO2-c~-thrombin in a dose-dependent man- 
ner (55 % inhibition at 20 #g/ml) (Fig. 4). This may indicate 
that the RGD domain in thrombin is only partially cryptic, 
and that additional neighboring sequences may assist in rec- 
ognition of this RGD sequence by the appropriate cell sur- 
face receptors. The low attachment-inducing activity of na- 
tive  ot-thrombin  (Fig.  1)  does  not  appear  to  be  due  to 
inactivation as a result of coating on a solid support, since 
all the other modified thrombin preparations retained their 
cell attachment activity both when present in solution (com- 
petition experiments) or when adsorbed onto plastic or glass 
surfaces.  Moreover,  plasric-bound  cx-thrombin  exhibited 
other functional properties such as esterolytic activity, in- 
duction  of  platelet  activation,  and  smooth  muscle  cell 
proliferation (data not shown). 
Effect of Specific  Thrombin Inhibitors on 
EC Attachment 
The question arose as to whether thrombin when forming a 
complex with either its physiological inhibitor ATIII or with 
the leech-derived high affinity inhibitor hirudin, retains at- 
tachment activity. To test this possibility, equimolar amounts 
of thrombin and ATIII in the presence of 0.3 U/ml heparin 
as a catalyst were used to coat the dishes. As shown in Fig. 
5,  45%  inhibition of EC  attachment to  NO2-ot-thrombin 
was observed.  This inhibition increased as the amount of 
ATIII increased, reaching 75 and 93 % inhibition at a ratio 
of 1:2 and 1:5 thrombin to ATIII, respectively. Under these 
conditions the amount of surface-adsorbed thrombin was not 
affected by the levels  of ATm, as indicated by the similar 
amounts of bound ~zq-o~-thrombin (data not shown). The 
specificity of this ATIII-induced inhibition of EC attachment 
to NOz-ct-thrombin  was demonstrated by a lack of inhibi- 
tion of EC adhesion to fibronectin, even at a  ratio of 1:5 
fibronectin/ATIII (Fig. 5). On the other hand, hirudin, the 
leech-derived high affinity inhibitor of thrombin, did not in- 
hibit EC attachment to NO2-ct-thrombin  even at a ratio of 
1:5 thrombin/hirudin (Fig. 5). 
Anriprothrombin antibodies, which also recognize throm- 
bin, inhibited in a dose-dependent manner EC attachment to 
thrombin. As demonstrated in Fig. 6,  complete inhibition 
was obtained at a 1:25 dilution of the antiserum, while there 
was no significant effect in the presence of preimmune se- 
rum. Th~s inhibition further demonstrates the specificity of 
EC attachment to thrombin. 
Effect of NOz-a-Thrombin on EC 
Cytoskeletal Organization 
As demonstrated in Fig. 7, NO2-ot-thrombin induced spread- 
ing of EC in a manner comparable to the subendothelial ex- 
tracellular matrix. The distribution of the microfilamentous 
cytoskeleton and the localization of  vinculin were studied by 
fluorescence microscopy on fixed and permeab'flized EC 
(Fig. 8). F-acrin  was visualized  by fluorochrome-labeled  phal- 
loidin and vinculin was identified with a specific monoclonal 
antibody that recognizes the mammalian form of vinculin. 
The extent of adhesion was evaluated by IRM, a technique 
that records the distance between the adhesion substratum 
and the cell ventral membrane. The smaller the distance the 
darker the signal intensity, black indicating tight adhesion. 
As shown in Fig. 8, upon plating of EC on NO2-a-thrombin 
the  cells  spread  and  organized  a  network  of  thick 
microfilamentous bundles.  Formation of stress  fibers oc- 
curred with appearance of vinculin streaks at their endings 
in  correspondence  with  focal  contacts.  These  cells  also 
showed multiple IRM black streaks that corresponded to the 
endings of stress fibers and distinct arrowhead-shaped vincu- 
lin speckles. Cell spreading and cytoskeletal organization on 
NO2-c~-thrombin  was  comparable  to  that observed  upon 
seeding of EC on a vitronectin substratum (15).  Immuno- 
fluorescence staining using anti-a, and anri-/~3 antibodies 
(Fig. 9) gave a peculiar pattern of  oval and arrowhead-shaped 
spots usually located at stress fiber endings. The amount of 
B3 clusters was, however, reduced in comparison to EC ad- 
bering to vitronectin (Fig.  9).  A  comparable distribution 
was observed in studies with HUVEC using anti-a, (LM142) 
mAb  (Fig.  9),  or  an  anti-c~,/33 complex mAb  (LM609), 
or anti-/~3 monoclonal and polyclonal antibodies (data not 
shown).  On BAEC only the polyclonal anti-/~3 antibodies 
gave a good staining at adhesion plaques, while staining with 
the monoclonal antibodies used in this study was less easily 
detectable, possibly due to lack of cross-reactivity. 
Anti-et,/~3 antibodies (LM609) blocked EC adhesion to 
NO2-c~-thrombin (Fig.  10)  and subsequent ceil spreading 
(not shown). In contrast, the mAb BIE5 and an anti-o~sB~ 
goat antiserum were ineffective at concentrations that mark- 
edly inhibited EC adhesion to fibronectin. These results in- 
dicate that the ot,/~3 integrin is involved in EC adhesion to 
NO2-ot-thrombin. 
We investigated the possible involvement of ECM proteins 
synthesized and secreted by EC during the process of cell 
adhesion to  NOra-thrombin.  For this purpose  EC  were 
treated with either emerine to block protein synthesis, or 
with monensin to prevent glycoprotein secretion.  No sig- 
nificant effect on the extent of cell adhesion was observed 
with both types of treatments (data not shown). 
Attachment of EC to Native a-Thrombin 
To explore the possibility that under certain conditions (i.e., 
limited autoproteolysis) the RGD region of native ot-throm- 
bin, can be exposed and function in promoting cell adhesion, 
the enzyme was preincubated at 37°C before coating of plas- 
tic surfaces. Fig. 11 demonstrated that t~-thrombin that was 
first incubated at 37°C was a potent inducer of EC attach- 
ment as compared to lack of such an activity in the absence 
of preincubation. This effect was rather rapid since a  sig- 
nificant attachment activity was observed even after a  15- 
min preincubation of  o~-thrombin at 37°C. When the protease 
inhibitor TLCK was present during preincubation of throm- 
bin at 37°C, the ability of  thrombin to induce EC attachment 
subsequent to coating of plastic surfaces was reduced by 
>65 % (data not shown). These data suggests that preincuba- 
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NO2-c~-thrombin.  Culture dishes were coated 
with 20  /Lg/ml of (a)  NO2-ct-thrombin or (b) 
BSA.  Dishes were also coated with (c)  natu- 
rally  produced  subendothelial  ECM.  Phase 
micrographs were taken after 2-h incubation at 
37°C with the cells. Bar,  100/~m. 
The Journal of Cell Biology, Volume 112, 1991  340 Figure 8.  HUVECs attach,  spread,  and organize focal contacts 
when plated on NO2-a-thrombin. Cell attachment was associated 
with (a)  stress fiber formation,  and (b) vinculin organization at 
stress fiber endings. These endings were found to correspond to 
dark spots in interference reflection microscopy (c). The arrow- 
heads in a, b, and c correspond to the position of a single focal con- 
tact.  Bar, 10 #m. 
tion at 37°C and the associated autoproteolysis of the throm- 
bin molecule may result in surface exposure of the RGD do- 
main in thrombin, which may hence mediate EC adhesion 
after adsorbance to the tissue culture plastic. 
Discussion 
Thrombin, the central bioregulatory enzyme in hemostasis, 
is actively engaged in governing thrombus formation. Dur- 
ing the initial phases of the hemostatic response after vessel 
injury, thrombin is generated to produce a fibrin network, 
promoting further fibrin dependent aggregation of platelets 
adherent to  the  exposed subendothelium  (7,  33,  35,  41). 
These processes contribute to the formation of thrombus that 
initially seals the vessel to prevent excessive blood loss. Dur- 
ing subsequent wound healing, after vessel injury, ECs initi- 
ate  local  repair  mechanisms  involving  cell  attachment, 
migration, and proliferation to renew the damaged vessel. 
The adhesive phenotype of endothelial cells appears to be a 
critical factor regulating this repair process. Therefore, to 
understand the molecular events involved in thrombus for- 
marion and wound healing, it is necessary to delineate struc- 
tural interactions between cells and molecules participating 
in these processes. 
In this report, we present data showing that the RGD se- 
quence within thrombin promotes EC adhesion, spreading, 
and cytoskeletal reorganization. Modifications of the throm- 
bin molecule either at the procoagulant or catalytic site gave 
rise to species of thrombin that were highly adhesive for en- 
dothelial cells. This was found for thrombin that was catalyt- 
ically blocked by MeSO2 at the active site serine or by the 
fibrinopeptide exosite affinity label.  ECs  attached also to 
3,-thrombin, exhibiting no procoagulant activity and a low 
proteolytic function. Furthermore, nitration of tyrosine resi- 
dues which yielded a reduced procoagulant activity, resulted 
in a  maximal induction of EC attachment.  Indeed, amino 
acid analysis shows the presence of a tyrosine residue located 
at  position  185  of thrombin  B-chain,  preceding the  only 
RGDA  sequence  in  the  protein  (residues  186-189).  This 
RGD sequence in thrombin is apparently hindered, located 
inwards towards the core of the enzyme and therefore is not 
exposed in the native molecule, which exhibits a very low at- 
tachment activity.  In  support of these findings  are recent 
crystallographic studies indicating that the RGD domain is 
not accessible on the surface of the thrombin molecule (8). 
Upon specific modifications, however, this region may be ex- 
posed, for example, by nitration of the tyrosine residue adja- 
cent to the RGD sequence. This tyrosine (Tyr-185) appar- 
ently plays a  significant role in  altering the conformation 
of ct-thrombin,  resulting in exposure of RGD sequence at 
an exosite domain.  The degree of nitration (eight or three 
nitrotyrosines per mole) did not affect significantly the at- 
tachment-promoting activity of the modified thrombin (data 
not shown). 
EC attachment was completely abolished in the presence of 
ATIZI, forming a  complex with NO2-ot-thrombin, suggest- 
ing that ATIH masks the RGD region in thrombin. In contrast, 
hirudin, a leech-derived protein (Mr •7,000)  with high affin- 
ity to thrombin, did not inhibit its attachment promoting ac- 
tivity. Hirudin has a negatively  charged tall (1, 19, 34), thought 
to bind to a region neighboring the catalytic site located up- 
stream to the RGD sequence at the frontal side of thrombin. 
The RGD domain is therefore an unlikely candidate for inter- 
action  with  hirudin  (21).  Complexes  of NO2-ot-thrombin 
and hirudin served as potent attachment substrates for EC, 
in correlation with the described thrombin-hirudin interac- 
tion regions (thrombin chemotactic and mitogenic domains) 
and the distinct RGD domain responsible for EC attachment. 
When anti-prothrombin antibodies were present during the 
adhesion assay, cell attachment was completely blocked, fur- 
ther reflecting the specific nature of EC-thrombin interac- 
tions. 
EC spreading on NO2-o~-thrombin was followed by actin 
microfilament  assembly,  and  appearance  of  interference 
reflective microscopy black streaks and vinculin speckles at 
stress fiber endings.  Qualitatively, this type of cellular re- 
sponses were comparable to those observed after seeding the 
cells on a  series of characteristic matrix proteins such as 
vitronectin, fibronectin, or von Willebrand factor (13, 15, 17, 
18).  This phenomenon is of particular relevance because it 
indicates that the plasma membrane has interacted with the 
substratum via specific receptors and that this interaction has 
triggered a cascade of events leading to the organization of 
Bar-Shavit et al. Endothelial  Cell Adhesion  to Thrombin  341 Figure 9.  Distribution of av receptors,/~3 receptors, arid F-actin HUVECs (a-f) and BAECs (g-j) were incubated (1.3  ×  10  5 cells/well) 
for 4 h  on coverslips coated with vitronectin (c, d, i, and j), NO2-.-thrombin (a, b, g, and h), or thrombin (e and f).  The cells were 
permeabilized and stained with anti-c~vmAb (LM142) (b, d, and f), rabbit anti-GpIIIa antiserum (MAR-2) (h and j), or F-PHD (a,  c, 
e, g, and 0. Plating of HUVECs on NO2-ct-thrombin supports spreading and stress fiber formation to a lesser extent than on vitronectin 
(compare a  and c and b  and d, respectively); txv clusters were fewer and more weakly stained, see arrowheads (b and d).  In HUVECs 
the organization of/33 was comparable to that of uv (not shown). Plating on ~x-thrombin did not result in stress fiber formation or integrin 
receptor organization (e and f). BAECs plated on NO2-tx-thrombin (g and h) adhered but exhibited a bit less spreading and stress fiber 
formation than on vitronectin (i and  j). Such reduced flattening was reflected in a less elaborate pattern of 133 receptor clustering and focal 
contact formation on NO2-tx-thrombin than on vitronectin (compare h  and j). Bar,  10/~m. 
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2~15°]  ]l~! ~  ~  ~  ceptor antibodies on  HUVECfibronectin  adhesion  to different  substrata. 
l oo 1 ~rr-~  HUVEC were seeded on NO2- 
a-thrombin  (100 #g/ml; A); 
so~  (3 #g/ml; B); or 
o  .  vitronectin (3 #g/ml; C). Be- 
A  B  c  fore  the  adhesion  assay 
HUVEC were incubated for 
30 min at 37°C with: buffer (z~); otvB3 antibody, LM609 mAb; 
(a); a5 antibody, B1E5 mAb, (ta); asBl goat antiserum (t~). When 
goat nonimmune serum or mAb 10E3 were  used, no change in cell 
adhesion was observed. Adhesion to BSA (1%  in coating) was 
7 +  1. Data are means + SEM of five replicates from one experi- 
ment out of four performed with comparable results. 
adhesion plaques in which vinculin and other proteins are as- 
sociated.  It  is  therefore  likely that the  effect of NO2-ot- 
thrombin on cell spreading and cytoskeletal organization is 
mediated by a specific recognition mechanism. 
Inhibition  studies  revealed  that an  anti-txvl$3 mAb  was 
able to block adhesion of EC to NO2-a-thrombin,  while 
anti-asBl antibodies were ineffective.  Vitronectin receptor 
(av~3) was also found to be clustered in focal contacts upon 
EC  adhesion  to  NO2-a-thrombin.  Altogether these  data 
strongly suggest that a,B3 plays a leading role in mediating 
EC interaction with NO2-ot-thrombin.  The vitronectin re- 
ceptor (39) is very  promiscuous and recognizes, besides vitro- 
nectin, also other substrata including yon Willebrand factor, 
and fibrinogen (11, 32). The data reported here provide evi- 
dence that this receptor binds modified thrombin as well, 
thus identifying a novel ligand for this integrin. Seeding of 
EC on NO2-a-thrombin resulted in deposition of fibronec- 
tin that could influence cell adhesion. However, blocking en- 
dogenous matrix formation by treatment with inhibitors of 
protein synthesis and secretion (14, 40), had no effect on EC 
adhesion  and  spreading  onto  NO2-a-thrombin  (data  not 
shown).  This  indicates that NO2-a-thrombin  itself could 
directly induce EC adhesion and cytoskeletal organization. 
120 ' 
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Figure 11.  Adhesion of EC to native a-thrombin. Culture dishes 
were coated with 20 #g/ml of a-thrombin (aTh), or with 20 #g/ml 
of thrombin that was first incubated in solution at 370C for 60 min 
(a);  30 rain (b); or 15 min (c). Cells were also incubated with 
dishes coated with BSA alone (None). The number of  attached ECs 
was determined by the methylene blue uptake assay. 100% attach- 
ment represents the number of cells attached to thrombin that was 
preincubated at 37°C for 60 min. This value was similar to that ob- 
tained on NO2-a-thrombin coated dishes under the same condi- 
tions. 
The  biological relevance of the  adhesive properties  of 
modified thrombin molecules remains to be fully elucidated. 
The native enzyme has very little adhesive properties, de- 
spite having an RGD domain. However,  it may still com- 
pete for adhesion to modified NO2-ot-thrombin (Fig. 4) and 
with other adhesive proteins, for example fibronectin (data 
not shown). The fact that thrombin molecule is composed of 
various functional domains some of which are exosite ex- 
posed regions and others like the RGD domain, are hin- 
dered, is intriguing. We have demonstrated that preincuba- 
tion of ot-thrombin at 37°C for a period of 15-60 min before 
coating of the plastic  surface resulted in potent adhesive 
properties (Fig. 11). This could in part be due to autoproteol- 
ysis of the enzyme (as was indeed indicated by the inhibitory 
effect of TLCK) and/or to other structural modifications of 
the molecule occurring during incubation at 37°C. We postu- 
late that the RGD site can be surface exposed to response to 
specific modifications and signals which may be triggered 
under stress or pathological conditions. In would healing and 
inflammatory  processes, extensive recruitment of  leukocytes 
takes place. Moreover, it has been demonstrated that throm- 
bin that is ubiquitous to vascular injury, is a potent chemo- 
taxin for mononuclear phagocytes (3). Therefore, we suggest 
that  during  tissue  repair  when  excess  of mononuclear- 
phagocytic cells (highly rich  in proteolytic enzymes) are 
present, these cells may act on thrombin in a manner that will 
modify the molecule and expose the RGD domain for direct 
participation in cellular attachment. The effect of various 
proteolytic enzymes (i.e.,  elastase, plasmin, cathepsin G, 
etc.) on thrombin attachment activity is under a current in- 
vestigation. 
In conclusion, we present evidence that certain modifica- 
tions of thrombin may result in "pointing out" of its RGD re- 
gion that may then be actively engaged in supporting EC 
adhesion and cytoskeletal reorganization. We suggest that 
thrombin, in addition to playing a pivotal role in hemostasis, 
participates in repair mechanisms and maintenance of the 
integrity of the internal vessel lining by acting as a matrix 
protein for EC.  Our data on the involvement of the otvB3 
integrin in promoting EC  adhesion to modified thrombin 
identify a new binding site for this molecule on EC. 
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